• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

J Clin Immunol . Prediction Model Based on the Combination of Cytokines and Lymphocyte Subsets for Prognosis of SARS-CoV-2 Infection

tetano

Editor, Senior Moderator
J Clin Immunol


. 2020 Jul 13.
doi: 10.1007/s10875-020-00821-7. Online ahead of print.
Prediction Model Based on the Combination of Cytokines and Lymphocyte Subsets for Prognosis of SARS-CoV-2 Infection


Ying Luo[SUP] 1 [/SUP], Liyan Mao[SUP] 1 [/SUP], Xu Yuan[SUP] 1 [/SUP], Ying Xue[SUP] 2 [/SUP], Qun Lin[SUP] 1 [/SUP], Guoxing Tang[SUP] 1 [/SUP], Huijuan Song[SUP] 1 [/SUP], Feng Wang[SUP] 3 [/SUP], Ziyong Sun[SUP] 4 [/SUP]



Affiliations

Abstract

Background: There are currently rare satisfactory markers for predicting the death of patients with coronavirus disease 2019 (COVID-19). The aim of this study is to establish a model based on the combination of serum cytokines and lymphocyte subsets for predicting the prognosis of the disease.
Methods: A total of 739 participants with COVID-19 were enrolled at Tongji Hospital from February to April 2020 and classified into fatal (n = 51) and survived (n = 688) groups according to the patient's outcome. Cytokine profile and lymphocyte subset analysis was performed simultaneously.
Results: The fatal patients exhibited a significant lower number of lymphocytes including B cells, CD4[SUP]+[/SUP] T cells, CD8[SUP]+[/SUP] T cells, and NK cells and remarkably higher concentrations of cytokines including interleukin-2 receptor, interleukin-6, interleukin-8, and tumor necrosis factor-α on admission compared with the survived subjects. A model based on the combination of interleukin-8 and the numbers of CD4[SUP]+[/SUP] T cells and NK cells showed a good performance in predicting the death of patients with COVID-19. When the threshold of 0.075 was used, the sensitivity and specificity of the prediction model were 90.20% and 90.26%, respectively. Meanwhile, interleukin-8 was found to have a potential value in predicting the length of hospital stay until death.
Conclusions: Significant increase of cytokines and decrease of lymphocyte subsets are found positively correlated with in-hospital death. A model based on the combination of three markers provides an attractive approach to predict the prognosis of COVID-19.

Keywords: Coronavirus disease 2019; cytokines; lymphocyte subsets; prognosis; severe acute respiratory syndrome coronavirus 2.
 
Back
Top Bottom